17-(1,5-Dimethyl-hexyl)-14-(1-hydroxy-ethyl)-4,4,10,13-tetramethyl-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

ID: ALA133834

PubChem CID: 44354271

Max Phase: Preclinical

Molecular Formula: C31H54O2

Molecular Weight: 458.77

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)CCC[C@@H](C)[C@H]1CC[C@@]2(C(C)O)C3=CCC4C(C)(C)[C@@H](O)CC[C@]4(C)C3CC[C@]12C

Standard InChI:  InChI=1S/C31H54O2/c1-20(2)10-9-11-21(3)23-15-19-31(22(4)32)25-12-13-26-28(5,6)27(33)16-17-29(26,7)24(25)14-18-30(23,31)8/h12,20-24,26-27,32-33H,9-11,13-19H2,1-8H3/t21-,22?,23-,24?,26?,27+,29-,30-,31-/m1/s1

Standard InChI Key:  BOQKRCLAJMWJDG-ZHLGQSRNSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  1  0  0  0  0  0999 V2000
    3.0042   -1.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2917   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0042   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8625   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5792   -1.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8625   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2917   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7917    0.0708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2917    0.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7917   -1.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5792   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1500   -1.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5792   -0.1792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750   -0.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5708   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0042   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5708   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0417    0.8583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0042    0.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6500   -0.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4208   -3.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7417   -3.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2875   -2.6750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7417   -2.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042    0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8500    1.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7167   -2.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4917    1.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2042    0.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7625   -0.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5667    0.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5125   -0.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7787    0.2315    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  5  1  0
  5  2  1  0
  6 12  1  0
  7  2  2  0
  8  6  1  0
  9  3  1  0
 10  3  1  0
 11  1  1  0
 12  7  1  0
 13  4  1  0
 14 10  1  0
 15 11  1  0
 16  8  1  0
  1 17  1  6
 18 13  1  0
  9 19  1  0
  3 20  1  1
  4 21  1  1
  8 22  1  0
  8 23  1  0
 16 24  1  1
 25 17  1  0
 26 27  1  0
 27 19  1  0
 17 28  1  0
 19 29  1  6
 30 26  1  0
 31 30  1  0
 32 31  1  0
 33 31  1  0
  9 15  1  0
 14  5  1  0
  6  4  1  0
 16 18  1  0
  9 34  1  6
M  END

Associated Targets(Human)

HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cyp51a1 Cytochrome P450 51 (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 458.77Molecular Weight (Monoisotopic): 458.4124AlogP: 7.78#Rotatable Bonds: 6
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 7.29CX LogD: 7.29
Aromatic Rings: Heavy Atoms: 33QED Weighted: 0.40Np Likeness Score: 2.67

References

1. Frye LL, Cusack KP, Leonard DA..  (1993)  32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis.,  36  (3): [PMID:8426367] [10.1021/jm00055a012]
2. Frye LL, Cusack KP, Leonard DA..  (1993)  32-Methyl-32-oxylanosterols: dual-action inhibitors of cholesterol biosynthesis.,  36  (3): [PMID:8426367] [10.1021/jm00055a012]

Source